Krsnaa Diagnostics Q2 FY26 Results: PAT up 5.8% to Rs 232 mn standalone
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.5 pts more than Nifty Microcap 250 and 9.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics Q2 FY26: standalone revenue Rs 1,828.82 mn (up 2.3% YoY), PAT Rs 232.39 mn (up 5.8%). Consolidated revenue up 10.5% to Rs 2,059.91 mn, PAT up 22.2% to Rs 239.45 mn. H1 consolidated revenue Rs 3,989.69 mn (up 11.9%). Quarterly EPS Rs 7.12 standalone, Rs 7.38 consolidated. Auditor flagged tax demand of Rs 513.86 mn as emphasis of matter; company has filed appeals and paid Rs 102.77 mn under protest, expects no material impact.
Modest revenue growth and steady PAT show stable operations. Pending tax demand of Rs 513.86 mn remains a watch item though management expects no material impact.